{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "12002806",
  "DateCompleted": {
    "Year": "2002",
    "Month": "05",
    "Day": "23"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "07",
    "Day": "01"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0024-3205",
      "JournalIssue": {
        "Volume": "70",
        "Issue": "18",
        "PubDate": {
          "Year": "2002",
          "Month": "Mar",
          "Day": "22"
        }
      },
      "Title": "Life sciences",
      "ISOAbbreviation": "Life Sci"
    },
    "ArticleTitle": "Effect of a mu-opioid receptor-selective antagonist on interleukin-6 fever.",
    "Pagination": {
      "StartPage": "2139",
      "EndPage": "2145",
      "MedlinePgn": "2139-45"
    },
    "Abstract": {
      "AbstractText": [
        "The endogenous opioid system has been found to be involved in fever caused by pyrogens. Recent work in our laboratory has demonstrated that the mu-opioid receptor is involved in interleukin-1beta (IL-1beta)- and in lipopolysaccharide (LPS)-induced fevers. In the present study, we have investigated the role of the mu-opioid receptor in the preoptic anterior hypothalamus (POAH) in fever induced by interleukin-6 (IL-6). Following stereotaxic implantation of a guide cannula into the POAH for microinjection, radio transmitters to monitor body temperature (Tb) continuously were inserted intraperitoneally. Adult male Sprague-Dawley rats were microinjected with 0.5 microg of the selective mu-opioid receptor antagonist, cyclic D-phe-Cys-Try-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP), into the POAH. Thirty min later, IL-6 (100 ng) was injected into the POAH. CTAP significantly blocked the IL-6 fever. CTAP alone had no effect on Tb during the 390-min recording period. These data indicate that mu-opioid receptors within the POAH mediate IL-6 fever and add to the increasing evidence that the opioid system is involved in the pathogenesis of fever in rats."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Center for Substance Abuse Research and Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA, USA. kbenamar@hotmail.com"
          }
        ],
        "LastName": "Benamar",
        "ForeName": "Khalid",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Geller",
        "ForeName": "Ellen B",
        "Initials": "EB"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Adler",
        "ForeName": "Martin W",
        "Initials": "MW"
      }
    ],
    "GrantList": [
      {
        "GrantID": "DA 00376",
        "Acronym": "DA",
        "Agency": "NIDA NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, U.S. Gov't, P.H.S."
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Netherlands",
    "MedlineTA": "Life Sci",
    "NlmUniqueID": "0375521",
    "ISSNLinking": "0024-3205"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "CTAP octapeptide"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Interleukin-6"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Narcotic Antagonists"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Peptide Fragments"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Peptides"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Receptors, Opioid, mu"
    },
    {
      "RegistryNumber": "51110-01-1",
      "NameOfSubstance": "Somatostatin"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Body Temperature"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Dose-Response Relationship, Drug"
    },
    {
      "QualifierName": [
        "chemically induced",
        "prevention & control"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [
        "drug effects",
        "metabolism"
      ],
      "DescriptorName": "Hypothalamus, Anterior"
    },
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Interleukin-6"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Narcotic Antagonists"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Peptide Fragments"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Peptides"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Rats"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Rats, Sprague-Dawley"
    },
    {
      "QualifierName": [
        "antagonists & inhibitors",
        "metabolism"
      ],
      "DescriptorName": "Receptors, Opioid, mu"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Somatostatin"
    }
  ]
}